Vonica A - Search Results

1

Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation.

Lesnik P, Dentan C, Vonica A, Moreau M, Chapman MJ. Lesnik P, et al. Among authors: vonica a. Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1121-30. doi: 10.1161/01.atv.15.8.1121. Arterioscler Thromb Vasc Biol. 1995. PMID: 7627705

2

Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a).

Lesnik P, Vonica A, Guérin M, Moreau M, Chapman MJ. Lesnik P, et al. Among authors: vonica a. Arterioscler Thromb. 1993 Jul;13(7):1066-75. doi: 10.1161/01.atv.13.7.1066. Arterioscler Thromb. 1993. PMID: 8318508

3

Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours.

Lacombe ML, Sastre-Garau X, Lascu I, Vonica A, Wallet V, Thiery JP, Véron M. Lacombe ML, et al. Among authors: vonica a. Eur J Cancer. 1991;27(10):1302-7. doi: 10.1016/0277-5379(91)90101-i. Eur J Cancer. 1991. PMID: 1659843

4

Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme.

Gilles AM, Presecan E, Vonica A, Lascu I. Gilles AM, et al. Among authors: vonica a. J Biol Chem. 1991 May 15;266(14):8784-9. J Biol Chem. 1991. PMID: 1851158 Free article.

5

Nucleoside diphosphate kinase from human erythrocytes: purification, molecular mass and subunit structure.

Presecan E, Vonica A, Lascu I. Presecan E, et al. Among authors: vonica a. FEBS Lett. 1989 Jul 3;250(2):629-32. doi: 10.1016/0014-5793(89)80811-7. FEBS Lett. 1989. PMID: 2546816 Free article.

6

Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories.

Cucuianu M, Cristea A, Vonica A, Lascu I. Cucuianu M, et al. Among authors: vonica a. Med Interne. 1988 Jul-Sep;26(3):191-7. Med Interne. 1988. PMID: 3187359

7

Functional and antigenic antithrombin III in angina pectoris and acute myocardial infarction patients.

Vonica A, Văgăonescu T, Cristea A, Stăncioiu N. Vonica A, et al. Med Interne. 1990 Oct-Dec;28(4):311-7. Med Interne. 1990. PMID: 2100876

8

The significance of low antithrombin III levels in cirrhosis.

Dumitraşcu DL, Radu D, Vonica A. Dumitraşcu DL, et al. Among authors: vonica a. Rom J Intern Med. 1991 Jul-Dec;29(3-4):151-4. Rom J Intern Med. 1991. PMID: 1784943

9

APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiation.

Lorenzo JP, Molla L, Amro EM, Ibarra IL, Ruf S, Neber C, Gkougkousis C, Ridani J, Subramani PG, Boulais J, Harjanto D, Vonica A, Di Noia JM, Dieterich C, Zaugg JB, Papavasiliou FN. Lorenzo JP, et al. Among authors: vonica a. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2312330121. doi: 10.1073/pnas.2312330121. Epub 2024 Apr 16. Proc Natl Acad Sci U S A. 2024. PMID: 38625936 Free PMC article.

10

Prdm3 and Prdm16 cooperatively maintain hematopoiesis and clonogenic potential.

McGlynn KA, Sun R, Vonica A, Rudzinskas S, Zhang Y, Perkins AS. McGlynn KA, et al. Among authors: vonica a. Exp Hematol. 2020 May;85:20-32.e3. doi: 10.1016/j.exphem.2020.04.010. Epub 2020 May 11. Exp Hematol. 2020. PMID: 32437910 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters